AllAfrica39m
Africa: New Dosing Guidance for Dolutegravir Allows Neonates Born to Mothers with HIV to Access this ARV Drug for the First Time - CROI Research
The PETITE-DTG study evaluated dolutegravir (DTG) — a drug that revolutionized HIV treatment in adults and children — in infants less than 28 days old, using a pediatric 5 mg dispersible tablet ...